Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CBX5 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-08 |
mRNA | PANK1 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-08 |
mRNA | ZNF250 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-08 |
mRNA | KANSL3 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-08 |
mRNA | MRPL9 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-08 |
mRNA | CLASRP | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
mRNA | HNRNPA1L2 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
mRNA | ZNF302 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-08 |
mRNA | ZNF100 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |
mRNA | PBRM1 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |